TickerFactsScreenerDevelopers

ENDRA Life Sciences Inc. (NDRA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$1.32M2017: -$3.30M2018: -$7.70M2019: -$8.59M2020: -$10.75M2021: -$11.12M2022: -$12.77M2023: -$9.55M2024: -$7.40M2025: -$5.18M-$5.18M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$5.18M+30.0%
2024-$7.40M+22.5%
2023-$9.55M+25.2%
2022-$12.77M-14.8%
2021-$11.12M-3.5%
2020-$10.75M-25.1%
2019-$8.59M-11.5%
2018-$7.70M-133.3%
2017-$3.30M-150.9%
2016-$1.32M—